Sunitinib benefits patients with renal cell carcinoma, study suggests
Friday, February 8, 2013 - 19:30
in Health & Medicine
Findings from clinical trial patients with metastatic renal cell carcinoma, a common kidney cancer, show they did not have accelerated tumor growth after treatment with sunitinib, in contrast to some study results in animals.